BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36411371)

  • 21. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
    Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rab23 Promotes Hepatocellular Carcinoma Cell Migration Via Rac1/TGF-β Signaling.
    Zhang L; Zhang B; You W; Li P; Kuang Y
    Pathol Oncol Res; 2020 Jan; 26(1):301-306. PubMed ID: 30191377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
    Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
    Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
    Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
    Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells.
    Li J; Zhang S; Hu Q; Zhang K; Jin J; Zheng X; Yin Z; Wang X
    Sci Rep; 2016 May; 6():26971. PubMed ID: 27231134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
    Xu K; Chen G; Li X; Wu X; Chang Z; Xu J; Zhu Y; Yin P; Liang X; Dong L
    Sci Rep; 2017 Feb; 7():41718. PubMed ID: 28176801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
    Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
    Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.
    Wu L; Cai C; Wang X; Liu M; Li X; Tang H
    FEBS Lett; 2011 May; 585(9):1322-30. PubMed ID: 21482222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
    Zhang L; Liang H; Xin Y
    Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-365 regulates liver cancer stem cells via RAC1 pathway.
    Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
    Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SH3-domain binding protein 1 in the tumor microenvironment promotes hepatocellular carcinoma metastasis through WAVE2 pathway.
    Tao Y; Hu K; Tan F; Zhang S; Zhou M; Luo J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18356-70. PubMed ID: 26933917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.